This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: The University of Tokyo, Yamaguchi University. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 1,356 
1 out of 89 Years Active: 2026
Title: The Innovations of Bengt Westermark
Introduction
Bengt Westermark is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of medical research, particularly in the area of brain tumors. His work has implications for both therapeutic and diagnostic applications.
Latest Patents
Westermark holds a patent titled "Therapeutic and Prophylactic Agent for Glioma, Brain Tumor Malignancy Marker, Brain Tumor Prognostic Marker, Method for Determining Malignancy and Prognosis of Brain Tumor and Antibody Inhibiting Tumor Proliferation." This patent addresses critical aspects of glioma treatment and prognosis, showcasing his innovative approach to tackling brain tumor malignancies. He has 1 patent to his name.
Career Highlights
Throughout his career, Westermark has been associated with prestigious institutions such as Yamaguchi University and The University of Tokyo. His work at these universities has allowed him to engage in cutting-edge research and contribute to advancements in medical science.
Collaborations
Westermark has collaborated with esteemed colleagues, including Kohei Miyazono and Ryo Tanabe. These partnerships have enriched his research and expanded the impact of his innovations in the medical field.
Conclusion
Bengt Westermark's contributions to the field of brain tumor research highlight his role as an influential inventor. His patent and collaborations reflect his commitment to advancing medical science and improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile